Abstract
Objectives: Pain and psychological disorders are the 2 most commonly occurring symptom clusters in patients with postherpetic neuralgia (PHN). This study aimed to investigate the risk factors for anxiety and depressive disorders in patients with PHN. Methods: Retrospectively, we examined the potential risk factors of anxiety and depression among patients with PHN from the clinic medical records of the Third Affiliated Hospital of Sun Yat-Sen University from 2017 to 2019. The Chinese version of the Hospital Anxiety and Depression Scale was used to assess anxiety and depression. Patients were retrospectively allocated to 2 groups – PHN with and without anxiety/depression – and compared to identify the differential patient characteristics. Results: Cases of 661 patients who were diagnosed with PHN were included. Anxiety and depression developed in 69.0% (456/661) and 65.8% (435/661) of the enrolled patients with PHN, respectively. Results of univariate regression analyses showed that female sex, magnitude of pain intensity, time from onset of rash and extent of spread of rashes were significantly associated with anxiety and depression in patients with PHN. Multivariate analysis revealed that both anxiety and depression states significantly correlated with female sex, magnitude of pain intensity, and extent of spread of rashes. Conclusions: Anxiety and depression were not uncommon in patients with PHN. Women with PHN who experience severe pain and develop extensive rashes have a high risk of developing anxiety and depressive disorders.
References
1.
Johnson
RW
, Rice
AS
. Clinical practice. Postherpetic neuralgia
. N Engl J Med
. 2014
Oct
;371
(16
):1526
–33
.
[PubMed]
0028-47932.
Thomas
SL
, Hall
AJ
. What does epidemiology tell us about risk factors for herpes zoster?
Lancet Infect Dis
. 2004
Jan
;4
(1
):26
–33
.
[PubMed]
1473-30993.
Lerman
SF
, Rudich
Z
, Brill
S
, Shalev
H
, Shahar
G
. Longitudinal associations between depression, anxiety, pain, and pain-related disability in chronic pain patients
. Psychosom Med
. 2015
Apr
;77
(3
):333
–41
.
[PubMed]
0033-31744.
Zhu
X
, Hu
P
, Fan
Z
, Zhan
W
, Wang
H
, Yang
Y
, et al Effects of mindfulness-based stress reduction on depression, anxiety, and pain in patients with postherpetic neuralgia
. J Nerv Ment Dis
. 2019
Jun
;207
(6
):482
–6
.
[PubMed]
0022-30185.
Schlereth
T
, Heiland
A
, Breimhorst
M
, Féchir
M
, Kern
U
, Magerl
W
, et al Association between pain, central sensitization and anxiety in postherpetic neuralgia
. Eur J Pain
. 2015
Feb
;19
(2
):193
–201
.
[PubMed]
1090-38016.
Kosson
D
, Malec-Milewska
M
, Gałązkowski
R
, Rzońca
P
. Analysis of anxiety, depression and aggression in patients attending pain clinics
. Int J Environ Res Public Health
. 2018
Dec
;15
(12
):2898
.
[PubMed]
1661-78277.
Dworkin
RH
, Gnann
JW
Jr, Oaklander
AL
, Raja
SN
, Schmader
KE
, Whitley
RJ
. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia
. J Pain
. 2008
Jan
;9
(1
Suppl 1
):S37
–44
.
[PubMed]
1526-59008.
Coen
PG
, Scott
F
, Leedham-Green
M
, Nia
T
, Jamil
A
, Johnson
RW
, et al Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?
Eur J Pain
. 2006
Nov
;10
(8
):695
–700
.
[PubMed]
1090-38019.
Zigmond
AS
, Snaith
RP
. The hospital anxiety and depression scale
. Acta Psychiatr Scand
. 1983
Jun
;67
(6
):361
–70
.
[PubMed]
0001-690X10.
Leung
CM
, Ho
S
, Kan
CS
, Hung
CH
, Chen
CN
. Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective
. Int J Psychosom
. 1993
;40
(1-4
):29
–34
.
[PubMed]
0884-829711.
Turk
DC
, Dworkin
RH
, Trudeau
JJ
, Benson
C
, Biondi
DM
, Katz
NP
, et al Validation of the hospital anxiety and depression scale in patients with acute low back pain
. J Pain
. 2015
Oct
;16
(10
):1012
–21
.
[PubMed]
1526-590012.
Drolet
M
, Brisson
M
, Schmader
KE
, Levin
MJ
, Johnson
R
, Oxman
MN
, et al The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study
. CMAJ
. 2010
Nov
;182
(16
):1731
–6
.
[PubMed]
0820-394613.
Naranjo
C
, Del Reguero
L
, Moratalla
G
, Hercberg
M
, Valenzuela
M
, Failde
I
. Anxiety, depression and sleep disorders in patients with diabetic neuropathic pain: a systematic review
. Expert Rev Neurother
. 2019
Dec
;19
(12
):1201
–9
.
[PubMed]
1473-717514.
Irwin
MR
, Miller
AH
. Depressive disorders and immunity: 20 years of progress and discovery
. Brain Behav Immun
. 2007
May
;21
(4
):374
–83
.
[PubMed]
0889-159115.
Muñoz-Quiles
C
, López-Lacort
M
, Orrico-Sánchez
A
, Díez-Domingo
J
. Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older
. J Infect
. 2018
Aug
;77
(2
):131
–6
.
[PubMed]
0163-445316.
Sato
K
, Adachi
K
, Nakamura
H
, Asano
K
, Watanabe
A
, Adachi
R
, et al Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: results from an observational, prospective, physician practice-based cohort study
. J Dermatol
. 2017
Apr
;44
(4
):414
–22
.
[PubMed]
0385-240717.
Schmaling
KB
, Nounou
ZA
. Incident chronic spinal pain and depressive disorders: data from the national comorbidity survey
. J Pain
. 2019
Apr
;20
(4
):481
–8
.
[PubMed]
1526-590018.
Gerrits
MM
, van Oppen
P
, van Marwijk
HW
, Penninx
BW
, van der Horst
HE
. Pain and the onset of depressive and anxiety disorders
. Pain
. 2014
Jan
;155
(1
):53
–9
.
[PubMed]
0304-395919.
Liu
XK
, Xiao
SY
, Zhou
L
, Hu
M
, Liu
HM
. Different predictors of pain severity across age and gender of a Chinese rural population: a cross-sectional survey
. BMJ Open
. 2018
Jul
;8
(7
):e020938
.
[PubMed]
2044-605520.
Nasser
SA
, Afify
EA
. Sex differences in pain and opioid mediated antinociception: modulatory role of gonadal hormones
. Life Sci
. 2019
Nov
;237
:116926
.
[PubMed]
0024-320521.
Cao
S
, Song
G
, Zhang
Y
, Xie
P
, Tu
Y
, Li
Y
, et al Abnormal local brain activity beyond the pain matrix in postherpetic neuralgia patients: a resting-state functional MRI study
. Pain Physician
. 2017
Feb
;20
(2
):E303
–14
.
[PubMed]
2150-114922.
Saguil
A
, Kane
S
, Mercado
M
, Lauters
R
. Herpes zoster and postherpetic neuralgia: prevention and management
. Am Fam Physician
. 2017
Nov
;96
(10
):656
–63
.
[PubMed]
1532-065023.
Gnann
JW
Jr, Whitley
RJ
. Clinical practice. Herpes zoster
. N Engl J Med
. 2002
Aug
;347
(5
):340
–6
.
[PubMed]
0028-4793© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
